Laurie Havanec - CVS Health Ex Officer
| CVS Stock | EUR 46.53 1.67 3.46% |
Insider
Laurie Havanec is Ex Officer of CVS Health Corp
| Age | 62 |
| Phone | 401-765-1500 |
| Web | https://www.cvshealth.com |
Laurie Havanec Latest Insider Activity
Tracking and analyzing the buying and selling activities of Laurie Havanec against CVS Health stock is an integral part of due diligence when investing in CVS Health. Laurie Havanec insider activity provides valuable insight into whether CVS Health is net buyers or sellers over its current business cycle. Note, CVS Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell CVS Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Laurie Havanec over six months ago Disposition of 6698 shares by Laurie Havanec of CVS Health at 76.43 subject to Rule 16b-3 |
CVS Health Management Efficiency
The company has return on total asset (ROA) of 0.0418 % which means that it generated a profit of $0.0418 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0568 %, meaning that it generated $0.0568 on every $100 dollars invested by stockholders. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Andrew Asher | Centene Corp | 54 | |
| Christopher Koster | Centene Corp | 58 | |
| PharmD PharmD | Humana Inc | 54 | |
| Katie Casso | Centene Corp | 41 | |
| Laurence PinotLacan | Ramsay Gnrale de | N/A | |
| Lisa Stoner | Humana Inc | N/A | |
| JeanMarc Coursier | Ramsay Gnrale de | N/A | |
| Marcin Radziwill | Medicover AB | N/A | |
| Andrew VallanceOwen | Medicover AB | 72 | |
| Jamel Ouanda | Ramsay Gnrale de | 47 | |
| Pierre Duperat | Ramsay Gnrale de | 54 | |
| Ashlee Knuckey | Centene Corp | N/A | |
| Jennifer Gilligan | Centene Corp | N/A | |
| Jerome Brice | Ramsay Gnrale de | N/A | |
| Brigitte Cachon | Ramsay Gnrale de | N/A | |
| Shannon Bagley | Centene Corp | 44 | |
| Staffan Ternstrom | Medicover AB | 58 | |
| Hanna Bjellquist | Medicover AB | N/A | |
| Isabelle Metref | Ramsay Gnrale de | N/A | |
| Georges Ichkanian | Ramsay Gnrale de | N/A | |
| Amy Fry | Humana Inc | N/A | |
Management Performance
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 |
CVS Health Corp Leadership Team
Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Moriarty, Executive Vice President General Counsel | ||
| Tilak Mandadi, Digital Data | ||
| Shawn Guertin, Ex CFO | ||
| Larry McGrath, Sr Relations | ||
| James Clark, Senior Vice President Chief Accounting Officer, Controller | ||
| Alan MD, Ex Services | ||
| David Falkowski, Ex Officer | ||
| Norman Greve, Chief Officer | ||
| Laurie Havanec, Ex Officer | ||
| Karen Lynch, CEO Pres |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 173.98 B | |||
| Shares Outstanding | 1.28 B | |||
| Shares Owned By Insiders | 0.41 % | |||
| Shares Owned By Institutions | 82.27 % | |||
| Price To Earning | 14.93 X | |||
| Price To Book | 1.85 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CVS Stock
When determining whether CVS Health Corp is a strong investment it is important to analyze CVS Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CVS Health's future performance. For an informed investment choice regarding CVS Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stocks Directory module to find actively traded stocks across global markets.